This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Northwestern University, The General Hospital Corporation. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 2,221 
2 out of 3,079 
Years Active: 2016-2018
Title: Innovations of Mohammad Khanfar
Introduction
Mohammad Khanfar is an accomplished inventor based in Evanston, IL (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of benzamide compounds. With a total of 3 patents, his work focuses on therapeutic applications that address critical health issues.
Latest Patents
Khanfar's latest patents include innovative benzamide compounds and related methods of use. These compounds are designed for the selective inhibition of the SIRT2 enzyme, which has therapeutic implications in the treatment of Huntington's disease. His research aims to provide new avenues for addressing this challenging neurological condition.
Career Highlights
Throughout his career, Khanfar has worked with prestigious institutions, including Northwestern University and The General Hospital Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Richard B. Silverman and Hua Wang. Their collaborative efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Mohammad Khanfar's contributions to the field of medicinal chemistry and his innovative patents highlight his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile